Market Research Report
North America Cannabis Testing Market Forecast 2019-2027
|Published by||Inkwood Research||Product code||556992|
|Published||Content info||125 Pages
Delivery time: 2-3 business days
|North America Cannabis Testing Market Forecast 2019-2027|
|Published: May 13, 2019||Content info: 125 Pages||
Cannabis testing is majorly carried out to detect the presence of heavy metals, impurities, residual solvents, pesticides or chemicals in order to assure the safety of cannabis for medicinal use. The North American cannabis testing market is expected to grow at a healthy CAGR of 10.85% over the forecast years of 2019-2027.
The presence of major industry players such as Restec Corporation and Thermo Fisher Inc. is hugely responsible for driving the market growth in this region. Also, the increasing use of cannabis testing in the medical research and treatment due to its legalization in over 25 US states has hugely contributed to the market expansion. The market segments include by testing method, end-users, cannabis type, and product & software segments. The cannabis testing market has evolved rapidly in the global scenario. The cannabis testing involves several drug testing methods which include the utility of cannabis considering medical prescription, norms & policies (Law) and medicines related to sports.
Eli Lilly, Shimadzu Corporation, AB Sciex LLC, Accelerated Technology Laboratories, Inc., Thermo Fisher Scientific, Inc., CannaSafe Analytics, SDpharma Labs LLC (PharmLabs™ LLC), Cannabilab, Steep Hill Halent Laboratories, Inc., Test Lab Amsterdam, Restek Corporation, Pharmalab, Urofins Proxy Laboratories, SC Laboratories, Inc., PerkinElmer, Inc., LabLynx, Inc., Sigma-Aldrich (Acquired By Merck Group), Digipath, Inc., Agilent Technologies, Inc., GenTech Scientific, Waters Corporation, and Anresco Laboratories are some of the noted market players in this region.